Patents by Inventor Colin R. Young

Colin R. Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240358119
    Abstract: Footwear uppers include a footwear upper base formed from one or more component parts and including: (i) an instep region including at least one of a tongue base region or instep base region and (ii) a heel-containing region. A bladder is engaged with the footwear upper. The bladder includes: (i) at least a first instep chamber engaged with the instep region, (ii) at least a first heel and/or ankle support chamber engaged with the heel-containing region, and (iii) a first fluid line connecting the first instep chamber and the first heel and/or ankle support chamber and placing the first instep chamber in fluid communication with the first heel and/or ankle support chamber. Fluid moving from the first instep chamber to the first heel and/or ankle support chamber (e.g., under force applied by a footwear securing strap) provides further support for the wearer's heel and/or ankle.
    Type: Application
    Filed: July 8, 2024
    Publication date: October 31, 2024
    Inventors: Patrick R. Case, Yoon Jeong Choi, James Molyneux, Colin Runkle, Bryan K. Youngs
  • Patent number: 12053053
    Abstract: Footwear uppers include a footwear upper base formed from one or more component parts and including: (i) an instep region including at least one of a tongue base region or instep base region and (ii) a heel-containing region. A bladder is engaged with the footwear upper. The bladder includes: (i) at least a first instep chamber engaged with the instep region, (ii) at least a first heel and/or ankle support chamber engaged with the heel-containing region, and (iii) a first fluid line connecting the first instep chamber and the first heel and/or ankle support chamber and placing the first instep chamber in fluid communication with the first heel and/or ankle support chamber. Fluid moving from the first instep chamber to the first heel and/or ankle support chamber (e.g., under force applied by a footwear securing strap) provides further support for the wearer's heel and/or ankle.
    Type: Grant
    Filed: October 19, 2022
    Date of Patent: August 6, 2024
    Assignee: NIKE, Inc.
    Inventors: Patrick R. Case, Yoon Jeong Choi, James Molyneux, Colin Runkle, Bryan K. Youngs
  • Patent number: 6465194
    Abstract: Hybridoma cell lines have been generated which produce and secrete monoclonal antibodies which selectively bind to 4,4′-dinitrocarbanilide (DNC), the active agent of nicarbazin. These hybridomas may be obtained by using as an immunization agent or immunogen, p-nitroaniline which has been conjugated to an immunogenic carrier. DNC in biological samples may be detected and quantified by contacting the sample with the antibodies to form a DNC/antibody immunocomplex when DNC is present, which immunocomplex may then be detected. The monoclonal antibodies also may be incorporated into kits for the detection and quantification of DNC and/or nicarbazin.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: October 15, 2002
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Ross C. Beier, Larry H. Stanker, Colin R. Young
  • Publication number: 20010039332
    Abstract: Hybridoma cell lines have been generated which produce and secrete monoclonal antibodies which selectively bind to 4,4′-dinitrocarbanilide (DNC), the active agent of nicarbazin. These hybridomas may be obtained by using as an immunization agent or immunogen, p-nitroaniline which has been conjugated to an immunogenic carrier. DNC in biological samples may be detected and quantified by contacting the sample with the antibodies to form a DNC/antibody immunocomplex when DNC is present, which immunocomplex may then be detected. The monoclonal antibodies also may be incorporated into kits for the detection and quantification of DNC and/or nicarbazin.
    Type: Application
    Filed: November 29, 2000
    Publication date: November 8, 2001
    Inventors: Ross C. Beier, Larry H. Stanker, Colin R. Young
  • Patent number: 5298416
    Abstract: An attenuated enterovirus or rhinovirus, suitable for use as a vaccine, has a reversed base pairing in the part, or in a part corresponding to the part, of the 5' non-coding region of the genome of poliovirus type 3 Leon strain shown below: ##STR1## A suitable attenuated poliovirus has the bases G and C at positions 469 and 534 respectively for a type 1 or type 2 poliovirus or at positions 472 and 537 respectively for a type 3 poliovirus.
    Type: Grant
    Filed: May 17, 1993
    Date of Patent: March 29, 1994
    Assignee: British Technology Group Ltd.
    Inventors: Jeffrey W. Almond, Philip D. Minor, Michael A. Skinner, Colin R. Young